PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1784347-2	1991	In addition, recent studies have shown that activation of either the 5-HT1A, the 5-HT1C or the 5-HT2 receptor triggers adrenal catecholamine release.	Catecholamines	127-140	5-hydroxytryptamine receptor 1A	Rattus norvegicus	69-75	
16675002-2	2006	These catecholamines can be modulated by the 5-HT(1A) serotonin receptor agonist 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).	Catecholamines	6-20	5-hydroxytryptamine receptor 1A	Rattus norvegicus	45-52	
1332098-2	1992	Because (1) acute LiCl administration increases sympathoadrenal function, and in turn plasma glucose levels, and (2) stimulation of either the 5-HT1A, the 5-HT1C or the 5-HT2 receptor subtype has adrenal catecholamine-releasing and hyperglycemic effects, we have investigated the influence of prior blockade of either of these receptor subtypes on plasma catecholamine and glucose responses to acute LiCl administration in conscious, catheterized rats.	Catecholamines	204-217	5-hydroxytryptamine receptor 1A	Rattus norvegicus	143-149	
10465692-4	1999	The hyperlocomotor effect of activating 5-HT1A sites also tended to decrease possibly as a result of a dependence of this response on the known depletion of catecholamines by reserpine.	Catecholamines	157-171	5-hydroxytryptamine receptor 1A	Rattus norvegicus	40-46	
1970616-1	1990	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) is a 5-HT1A receptor-selective agonist that has recently been reported to trigger adrenal catecholamine release and hyperglycemia.	Catecholamines	141-154	5-hydroxytryptamine receptor 1A	Rattus norvegicus	56-62